Q：这些探针染细胞，有没有细胞特异性？会不会 293 细胞不好染， MSC 好染？

A：由于这些染料是亲脂性染料，是通过插入到脂质膜中进而被激光激发观察，对于动植物细胞没有

特异性。

Q：这些探针荧光探针装载完多久后观察？

A：为减少各种可能的误差，尽量缩短探针装载后到仪器测定所用的时间(刺激时间除外)。

Q：这些探针染色细胞后，对细胞有毒性吗？

A：荧光探针类产品对活细胞都会有一定的毒性，因此建议在染色处理完成后应尽快完成检测和观察。

Q：为什么染色后发现荧光颜色较浅，应怎么操作进行改进？

A：可以尝试增加染色的时间和浓度。

Q：要看几个小时过程中活细胞的形态变化，应该怎么选？

A：通常使用亲脂性花青染料，如 DiI，DiO，DiD 或 DiR。

Q：DiRIodide(DiIC18(7))该探针在进行HPLC检测时该如何设置？

A：请使用正向色谱柱； 氯仿/甲醇～10:1。

[1] Wu J, Song D, Li Z, et al. Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis. Cell Res. 2020;30(9):794-809. doi:10.1038/s41422-020-0354-1(IF:20.507)

[2] Qin W, Xu W, Wang L, et al. Bacteria-Elicited Specific Thrombosis Utilizing Acid-Induced Cytolysin A Expression to Enable Potent Tumor Therapy. Adv Sci (Weinh). 2022;9(15):e2105086. doi:10.1002/advs.202105086(IF:16.806)

[3] Jiang YL, Wang ZX, Liu XX, et al. The Protective Effects of Osteocyte-Derived Extracellular Vesicles Against Alzheimer's Disease Diminished with Aging. Adv Sci (Weinh). 2022;9(17):e2105316. doi:10.1002/advs.202105316(IF:16.806)

[4] Chen H, Li Y, Wang Y, et al. An Engineered Bacteria-Hybrid Microrobot with the Magnetothermal Bioswitch for Remotely Collective Perception and Imaging-Guided Cancer Treatment [published online ahead of print, 2022 Mar 28]. ACS Nano. 2022;10.1021/acsnano.1c11601. doi:10.1021/acsnano.1c11601(IF:15.881)

[5] Gu Y, Lai S, Dong Y, et al. AZD9291 Resistance Reversal Activity of a pH-Sensitive Nanocarrier Dual-Loaded with Chloroquine and FGFR1 Inhibitor in NSCLC. Adv Sci (Weinh). 2020;8(2):2002922. Published 2020 Dec 4. doi:10.1002/advs.202002922(IF:15.840)

[6] Gao Y, Yang SC, Zhu MH, et al. Metal Phenolic Network-Integrated Multistage Nanosystem for Enhanced Drug Delivery to Solid Tumors. Small. 2021;17(29):e2100789. doi:10.1002/smll.202100789(IF:13.281)

[7] Guo Q, Chen C, Wu Z, et al. Engineered PD-1/TIGIT dual-activating cell-membrane nanoparticles with dexamethasone act synergistically to shape the effector T cell/Treg balance and alleviate systemic lupus erythematosus. Biomaterials. 2022;285:121517. doi:10.1016/j.biomaterials.2022.121517(IF:12.479)

[8] Liu F, Dai Z, Cheng Q, et al. LncRNA-targeting bio-scaffold mediates triple immune effects for postoperative colorectal cancer immunotherapy. Biomaterials. 2022;284:121485. doi:10.1016/j.biomaterials.2022.121485(IF:12.479)

[9] Qu F, Wang P, Zhang K, et al. Manipulation of Mitophagy by "All-in-One" nanosensitizer augments sonodynamic glioma therapy [published correction appears in Autophagy. 2022 Feb;18(2):470]. Autophagy. 2020;16(8):1413-1435. doi:10.1080/15548627.2019.1687210(IF:11.059)

[10] Li L, He D, Guo Q, et al. Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer. J Nanobiotechnology. 2022;20(1):50. Published 2022 Jan 25. doi:10.1186/s12951-022-01264-5(IF:10.435)

[11] Dou Y, Xie J, Tan Y, Zhang M, Zhao Y, Liu X. Neurotransmitter-stimulated neuron-derived sEVs have opposite effects on amyloid β-induced neuronal damage. J Nanobiotechnology. 2021;19(1):324. Published 2021 Oct 15. doi:10.1186/s12951-021-01070-5(IF:10.435)

[12] Qi N, Zhang S, Zhou X, et al. Combined integrin α_vβ₃ and lactoferrin receptor targeted docetaxel liposomes enhance the brain targeting effect and anti-glioma effect. J Nanobiotechnology. 2021;19(1):446. Published 2021 Dec 23. doi:10.1186/s12951-021-01180-0(IF:10.435)

[13] Huang L, Yan W, Cai B, et al. Dual-engineered, "Trojanized" macrophages bio-modally eradicate tumors through biologically and photothermally deconstructing cancer cells in an on-demand, NIR-commanded, self-explosive manner. Biomaterials. 2020;250:120021. doi:10.1016/j.biomaterials.2020.120021(IF:10.317)

[14] Chen C, Chen Y, Li M, et al. Functional decellularized fibrocartilaginous matrix graft for rotator cuff enthesis regeneration: A novel technique to avoid in-vitro loading of cells. Biomaterials. 2020;250:119996. doi:10.1016/j.biomaterials.2020.119996(IF:10.317)

[15] Li YJ, Wu JY, Hu XB, Ding T, Tang T, Xiang DX. Biomimetic Liposome with Surface-Bound Elastase for Enhanced Tumor Penetration and Chemo-Immumotherapy. Adv Healthc Mater. 2021;10(19):e2100794. doi:10.1002/adhm.202100794(IF:9.933)

[16] Dong J, Zhu C, Zhang F, Zhou Z, Sun M. "Attractive/adhesion force" dual-regulatory nanogels capable of CXCR4 antagonism and autophagy inhibition for the treatment of metastatic breast cancer. J Control Release. 2022;341:892-903. doi:10.1016/j.jconrel.2021.12.026(IF:9.776)

[17] Liu S, Xu J, Liu Y, et al. Neutrophil-Biomimetic "Nanobuffer" for Remodeling the Microenvironment in the Infarct Core and Protecting Neurons in the Penumbra via Neutralization of Detrimental Factors to Treat Ischemic Stroke. ACS Appl Mater Interfaces. 2022;14(24):27743-27761. doi:10.1021/acsami.2c09020(IF:9.229)

[18] Li YJ, Wu JY, Wang JM, Hu XB, Cai JX, Xiang DX. Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer. Acta Biomater. 2020;101:519-530. doi:10.1016/j.actbio.2019.10.022(IF:8.947)

[19] Kang S, Duan W, Zhang S, Chen D, Feng J, Qi N. Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma. Theranostics. 2020;10(10):4308-4322. Published 2020 Mar 4. doi:10.7150/thno.41322(IF:8.579)

[20] Xu C, Liu W, Hu Y, Li W, Di W. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy. Theranostics. 2020;10(7):3325-3339. Published 2020 Feb 10. doi:10.7150/thno.41228(IF:8.579)

[21] Zhang F, Yan Y, Peng W, et al. PARK7 promotes repair in early steroid-induced osteonecrosis of the femoral head by enhancing resistance to stress-induced apoptosis in bone marrow mesenchymal stem cells via regulation of the Nrf2 signaling pathway. Cell Death Dis. 2021;12(10):940. Published 2021 Oct 13. doi:10.1038/s41419-021-04226-1(IF:8.469)

[22] Ou T, Yang W, Li W, et al. SIRT5 deficiency enhances the proliferative and therapeutic capacities of adipose-derived mesenchymal stem cells via metabolic switching. Clin Transl Med. 2020;10(5):e172. doi:10.1002/ctm2.172(IF:7.919)

[23] Song P, Song N, Li L, Wu M, Lu Z, Zhao X. Angiopep-2-Modified Carboxymethyl Chitosan-Based pH/Reduction Dual-Stimuli-Responsive Nanogels for Enhanced Targeting Glioblastoma. Biomacromolecules. 2021;22(7):2921-2934. doi:10.1021/acs.biomac.1c00314(IF:6.988)

[24] Liu D, Shu M, Liu W, et al. Binary scaffold facilitates in situ regeneration of axons and neurons for complete spinal cord injury repair. Biomater Sci. 2021;9(8):2955-2971. doi:10.1039/d0bm02212h(IF:6.843)

[25] Le Z, He Z, Liu H, et al. Orally administrable polyphenol-based nanoparticles achieve anti-inflammation and antitumor treatment of colon diseases [published online ahead of print, 2022 Jun 21]. Biomater Sci. 2022;10.1039/d2bm00540a. doi:10.1039/d2bm00540a(IF:6.843)

[26] Wu JY, Li YJ, Hu XB, Huang S, Xiang DX. Preservation of small extracellular vesicles for functional analysis and therapeutic applications: a comparative evaluation of storage conditions. Drug Deliv. 2021;28(1):162-170. doi:10.1080/10717544.2020.1869866(IF:6.419)

[27] Li G, He H, Zheng G, et al. Direct Detection of Pulmonary Fibrosis by Near-Infrared-Responsive Biomimetic Platelets. Int J Nanomedicine. 2022;17:151-162. Published 2022 Jan 10. doi:10.2147/IJN.S334331(IF:6.400)

[28] Zhang H, Wang L, Li Z, Ji Y, Wu Z, He Q. Biosafety evaluation of dual-responsive neutrobots [published online ahead of print, 2022 Jul 1]. J Mater Chem B. 2022;10.1039/d2tb00938b. doi:10.1039/d2tb00938b(IF:6.331)

[29] Zhang P, Dong B, Zeng E, et al. In Vivo Tracking of Multiple Tumor Exosomes Labeled by Phospholipid-Based Bioorthogonal Conjugation. Anal Chem. 2018;90(19):11273-11279. doi:10.1021/acs.analchem.8b01506(IF:6.042)

[30] Yan H, Rong L, Xiao D, et al. Injectable and self-healing hydrogel as a stem cells carrier for treatment of diabetic erectile dysfunction. Mater Sci Eng C Mater Biol Appl. 2020;116:111214. doi:10.1016/j.msec.2020.111214(IF:5.880)

[31] Zhang W, Liu L, Su H, et al. Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix. Br J Cancer. 2019;121(10):837-845. doi:10.1038/s41416-019-0578-3(IF:5.416)

[32] Zhang G, Jiang B, Wu C, et al. Thin platelet-like COF nanocomposites for blood brain barrier transport and inhibition of brain metastasis from renal cancer. J Mater Chem B. 2020;8(20):4475-4488. doi:10.1039/d0tb00724b(IF:5.344)

[33] Wang Z, Yang C, Li L, et al. CD62L^dim Neutrophils Specifically Migrate to the Lung and Participate in the Formation of the Pre-Metastatic Niche of Breast Cancer. Front Oncol. 2020;10:540484. Published 2020 Oct 15. doi:10.3389/fonc.2020.540484(IF:4.848)

[34] Fang Q, Zhai M, Wu S, et al. Adipocyte-derived stem cell-based gene therapy upon adipogenic differentiation on microcarriers attenuates type 1 diabetes in mice. Stem Cell Res Ther. 2019;10(1):36. Published 2019 Jan 22. doi:10.1186/s13287-019-1135-y(IF:4.627)

[35] Di J, Du Z, Wu K, et al. Biodistribution and Non-linear Gene Expression of mRNA LNPs Affected by Delivery Route and Particle Size. Pharm Res. 2022;39(1):105-114. doi:10.1007/s11095-022-03166-5(IF:4.200)

[36] Qu C, Li J, Zhou Y, et al. Targeted Delivery of Doxorubicin via CD147-Mediated ROS/pH Dual-Sensitive Nanomicelles for the Efficient Therapy of Hepatocellular Carcinoma. AAPS J. 2018;20(2):34. Published 2018 Feb 23. doi:10.1208/s12248-018-0195-8(IF:3.804)

[37] Li X, Tang M. Exosomes released from M2 macrophages transfer miR-221-3p contributed to EOC progression through targeting CDKN1B. Cancer Med. 2020;9(16):5976-5988. doi:10.1002/cam4.3252(IF:3.491)